BioAtla faces Nasdaq delisting; trading to suspend Aug 31

BioAtla, Inc.

Nasdaq Listing Council affirmed delisting on Aug 26, 2026; suspension at open Aug 31, 2026.
Delisting due to bid price below $1.00 and failure to meet $2.5M stockholders' equity requirement.
Company expects OTC Markets quotation under ticker BCAB; liquidity and trading price may be materially affected.
Strategic review process initiated March 2026 to explore shareholder value alternatives remains ongoing.

Featured in Daily 8-K Digest

Selected #3 for 2026-08-28. Read digest

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.